News

TriLink BioTechnologies, a Maravai LifeSciences company and global provider of life science reagents and services, has joined forces with Johns Hopkins University to accelerate transformational research in RNA therapeutics and discovery by establishing a new center within the Johns...

Life science group Sartorius is collaborating with biopharmaceutical company Sanofi to develop an end-to-end platform for integrated and continuous downstream bioprocessing (ICB). Integrated continuous biomanufacturing is an advanced approach to the production of biopharmaceuticals, which aims to maximize efficiency by...

AbbVie and Gilgamesh Pharmaceuticals entered a collaboration and option-to-license agreement to develop next-generation therapies for psychiatric disorders. This collaboration will leverage AbbVie's expertise in psychiatry and Gilgamesh's research platform to discover novel neuroplastogens. Under the agreement, the companies have agreed...

Boehringer Ingelheim has entered an agreement with Quallent Pharmaceuticals, a private label pharmaceutical distributor, to help expand patient access to citrate-free adalimumab-adbm, Boehringer's biosimilar to Humira (adalimumab), in the U.S. Under the terms of the agreement, Boehringer Ingelheim will manufacture...

Fulcrum Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing small molecules, has entered into a collaboration and license agreement with Sanofi for the development and commercialization of losmapimod, an oral small molecule being investigated for the treatment of...

Aldevron, a global manufacturer of DNA, RNA, and proteins used in cell and gene therapies and vaccine development, has entered a strategic partnership with Acuitas Therapeutics, Inc., a private biotechnology company specializing in the development of delivery systems for...

It doesn’t come as a surprise when we put forth the fact that lab space happens to be a very exciting opportunity. However, most of the labs happen to have very few opportunities to create the space that goes...